MINNEAPOLIS, July 25, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment ...

Tactile Systems Technology, Inc. announced at the ASCO 2025 Annual Meeting new clinical data showing that its Flexitouch Plus device significantly improves clinical outcomes and quality of life for ...

Tactile Systems produces medical devices for lymphedema and chronic venous insufficiency, with Flexitouch Plus being the flagship product and key revenue driver. The company's products are covered by ...

MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...

First, our third-generation Flexitouch System, the Flexitouch Plus, was successfully introduced to our prescribing customer base in the second quarter. The features and benefits of this new design ...

Tactile Medical Systems had to drop its stock-offering price a year ago in a tough market to go public at $10 per share in order to raise nearly $50 million for the now-surging northeast Minneapolis ...